# Combination Treatment Study for Memory Impairment and Depression

> **NCT01658228** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 86 (actual)

## Conditions studied

- Depression
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Placebo
- **DRUG:** Citalopram
- **DRUG:** Venlafaxine

## Key facts

- **NCT ID:** NCT01658228
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2017-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658228, "Combination Treatment Study for Memory Impairment and Depression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01658228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*